Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):212–219. doi: 10.1016/j.ijrobp.2009.04.026

Table 1.

Survival studies results following therapy with placebo/sham RT, TMZ, RT or RT/TMZ for 20 GBM xenograft lines

placebo TMZ RT RT/TMZ
GBM# Rx
day
n survival,
days
n survival,
days
n survival,
days
n survival,
days
GBM5 22 8 55 10 321 10 139 9 349
GBM6 37 8 41 6 57 7 42 4 98
GBM8 44 8 58.5 8 123.5 8 107 8 189
GBM10 36 7 41 7 55 9 66 6 76
GBM12 11 10 15 10 53 10 37 10 85.5
GBM14 24 10 33 10 186 10 55.5 9 188
GBM15 29 10 54 10 252.5 9 250 10 252
GBM16 23 8 47.5 8 325.5 8 64 8 343
GBM22 38 8 43 8 154.5 8 43 8 325.5
GBM26 65 8 82.5 8 99.5 7 130 7 130
GBM28 30 8 33 7 56 7 68 8 82.5
GBM34 46 8 85 8 366.5 8 156 7 391
GBM36 44 8 125.5 8 228.5 8 194.5 8 307
GBM38 45 9 55 10 80 9 57 9 75
GBM39 28 10 31 10 120 10 50.5 10 202
GBM43 22 5 24 8 43 7 41 5 55
GBM44 31 9 35 7 59 9 104 10 113
GBM46 30 10 45 10 51 9 104 10 114.5
GBM58 51 10 91.5 10 102 9 100 10 111
GBM59 39 9 46 9 90 9 74 10 254

Rx day - number of days following tumor implantation that the 5-day therapy course was completed.

n - number of animals in each treatment group.

Survival - indicates the median survival in days for the indicated treatment.